The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis

Journal of Rheumatology

Volumn 27, Issue 11, 2000, Pages 2545-2550

  Kamper, E F ^a   Kopeikina, L T ^a   Trontzas, P ^a   Potamianou, A ^a   Tsiroglou, E ^a   Stavridis, J C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Fibrinolytic variables; Intercellular adhesion molecule 1; Interleukin 10; Interleukin 6; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; FIBRINOLYSIS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033747393     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Etiology and pathogenesis of rheumatoid arthritis
2. Adhesion molecules: A rheumatologic perspective
3. Mobilization of fibrinolytic enzymes in synovial fluid and plasma of rheumatoid arthritis and spondyloarthropathy and their relation to radiological destruction
4. Imbalance of tissue-type plasminogen activator and its specific inhibitor in patients with rheumatoid arthritis associated with disease activity
5. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
6. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells
7. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
8. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products
9. Interleukin-6 stimulates coagulation, not fibrinolysis in humans
10. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons
11. Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases by human synovial and skin fibroblasts
12. Role of cytokines in rheumatoid arthritis
13. Interleukin (IL)-10 inhibits nuclear factor kappa B activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
14. Adhesion molecules in rheumatoid arthritis: Role in the pathogenesis and prospects for therapy
15. Adhesion receptors of the immune system
16. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells
17. Cytokine inter-relationships and their association with disease activity in arthritis
18. A form of circulating ICAM-1 in human serum
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. A disease activity index: Its use in clinical trials and disease assessment in patients with rheumatoid arthritis
21. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis
22. Alpha2-plasmin inhibitor-plasmin complexes in synovial fluid
23. Disease severity in rheumatoid arthritis: Relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio neopterin, and fibrin D-dimer to traditional severity and factional measures
24. Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity
25. Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis
26. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis
27. Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis
28. Circulating soluble tumor necrosis factor receptors, interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy
29. Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells
30. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins
31. Pathogenesis of disseminated intravascular coagulation in sepsis
32. Progress of fibrinolysis during tumour necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1 and fibrin(ogen) degradation products
33. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
34. The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells
35. Vascular smooth muscle cells potential plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: Evidence for a specific tissue-type plasminogen activator receptor on these cells